Clinical Trial Update: New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on azilsartan for stronger blood pressure lowering in hypertension; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Edarbi (azilsartan medoxomil)

Snippet

Sponsor: Nara Medical University | Conditions: Hypertension | Phase 4 | Status: COMPLETED